Formulation and evaluation of polymeric nanoparticles of an antihypetensive drug for gastroretention
The aim of present study was to formulate and evaluate nanoparticles of carvedilol by using different hydrophilic polymers. Carvedilol was selected as a suitable drug for gastro- retentive nanoparticles due to its short half life, low bioavailability, high frequency of administration, and narrow absorption window in stomach and upper part of GIT. The nano-precipitation method was used to prepare nanoparticles so as to avoid both chlorinated solvents and surfactants to prevent their toxic effect on the body. Nanoparticles of carvedilol were prepared by using hydrophilic polymers such as HPMC K100M, chitosan, and gelatin. The prepared formulations were then characterized for particle size, polydispersity index, zeta potential, loading efficiency, encapsulation efficiency and drug-excipient compatibility. The prepared nanoparticulate formulations of carvedilol with different polymers in 1:1 ratio have shown particle size in the range of 250.12-743.07 nm, polydispersity index (PDI) in the range of 0.681-1.0, zeta potential in the range of -14.2 to +33.2 mV, loading efficiency in the range of 8.74-17.54%, and entrapment efficiency in the range of 55.7%-74.2%. Nanoparticulate formulation prepared with chitosan in 1:1 ratio showed satisfactory results i.e. average particle size 312.04 nm, polydispersity index 0.681, zeta potential 33.2 mV, loading efficiency 17.54%, and entrapment efficiency 73.4%. FTIR study concluded that no major interaction occurred between the drug and polymers used in the present study.
Keywords: Nanoparticles; gastro-retentive; nano-precipitation, polydispersity index, zeta potential; entrapment efficiency.
2. Shashikanth D. Barhate, Yogesh S. Rupnar, Rupesh M. Sonvane et al. Formulation and evaluation of floating microspheres of ketorolac trometamol, IJPRD. 2009; 1(9):1-8
3. Atul D karande, Pramod G. Yeole. Comparative assessment of different dissolution apparatus for floating drug delivery systems. Dissolution technologies. 2006: 20-26
4. Dhakar RC, Maurya SD, Saluja V. From formulation variables to drug entrapment efficiency of microspheres: A technical review. JDDT. 2012; 2(6):128-133.
5. Sachin B Somwanshi, Ramdas T Dolas, Vikrant K Nikam., Floating multiparticulate oral sustained release drug delivery system. J. Chem. Pharm. Res., 2011; 3(1):536-547.
6. Ramesh C Nagarwal, Devendra N Ridhurkar, J K Pandit. In-vitro release kinetics and bioavailability of gastroretentive cinnarizine HCl tablet. AAPS PharmaSci Tech. 2010; 11(1): 294-303.
7. Barratt G (1999). Characterization of colloidal drug carrier systems with zeta potential measurements. Pharma Tech Eur 11: 25–32.
8. Deshpande AA, Rhodes TN and Shah H. Controlled release drug delivery systems for prolonged gastric residence an overview. Drug dev Ind pharm 1996; 22:531-539.
9. Garg R and Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008; 7:1055-1066.
10. Hejazi R and Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release 2003; 89:151-165.
11. Yin J., Burgess C., Shu L., Shumyak S., Raymond N., Xu L., Li L., He S.M. Estrogen anchored nanomicelles for combinational drug delivery with enhanced therapeutic efficacy: a proteomics guided investigation for multifunctional nanotherapeutics. Journal of Drug Delivery and Therapeutics, 2018; 8(2):41-53. https://doi.org/10.22270/jddt.v8i2.1662
12. Lueben HL, Lehr CM, Rentel CO, Noach ABJ, Boer AGD, Verhoef JC and Junginger HE. Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Release 1994; 29:329-338
13. M, Indumathy R, Sreeram KJ and Balachandran U. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull Mater Sci 2008; 31:93-96.
14. Park K and Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharm 1984; 19:107-127.
15. Sharma, M., Sharma, R., & Jain, D. Preparation, characterization and evaluation of nebivolol loaded chitosan nanoparticles. Journal of Drug Delivery and Therapeutics, 2018; 8(2):118-122. https://doi.org/10.22270/jddt.v8i2.1730
16. Pignatello R, Ricupero N, Bucolo, Maugeri F, Maltese A and Puglisi G. Preparation and characterization of eudragit retard nanasuspensions for the ocular delivery of cloricromene. AAPS Pharm SciTech 2006; 24(7): E27.
17. Rao PB, Kottan NA and Snehith VS. Development of gastroretentive drug delivery system of cephalexin by using factorial design. ARS Pharmaceutica 2005; 50:8-24.
18. Rouge N, Buri P and Doelke E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery. Int J Pharm 1996; 136:117-139.
19. Zoghbi A., & Wang B. Carvedilol solubility enhancement by inclusion complexation and solid dispersion: review. Journal of Drug Delivery and Therapeutics, 2015; 5(2):1-8. https://doi.org/10.22270/jddt.v5i2.1074
20. Schubert MA and Muller GCC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharm Biopharm 2003; 55:125- 131
21. Ramesh Y., Reddigari J., Kothapalli C.B. Formulation and evaluation of tropicamide in-situ gels loaded solid lipid nanoparticles for ocular drug delivery. Journal of Drug Delivery and Therapeutics, 2018; 8(2):194-207. https://doi.org/10.22270/jddt.v8i2.1765
22. Li L., Li S., Zhang L., Ma Y., Yang J., Yang Y., Wu H., Zhang, L., & Zhang, G. Study on the biological safety of TiO2 nanoparticles based on the oxidative stress pathway. Journal of Drug Delivery and Therapeutics, 2018; 8(3):116-123. https://doi.org/10.22270/jddt.v8i3.1773
23. Streubel A, Siepmann J and Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Deliv 2006; 3:217-233.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).